International Women's Day - March 8th, 2017
 
login-logo
WHRI March E-Blast
 
 

WHRI's International Women's Day Event

Join us on the evening of March 8th for a special public presentation in honour of International Women's Day (IWD). The theme for IWD 2017 is #BeBoldForChange - a call to action for a more gender-inclusive world.

Our Vancouver-based event will include brief presentations by local experts in areas of women's health who will be discussing the latest recommendations for breast health, gynecologic cancer screening, mental wellness and sexual health. 

This event has limited seating. Please RSVP to  whri_cwbc@cw.bc.ca in order to secure your spot.

EVENT DETAILS:

Presenters: Drs. Jessica McAlpine, Marie Josée Cloutier, Joti Samra & Lori Brotto

Date: Wednesday, March 8th, 2017

Time: 7:00pm - 8:30pm

Location: Jewish Community Centre - 950 41st Ave West, Vancouver, BC

 
 

WHRI Early Career Investigator and Knowledge Translation Awards

We have recently launched two new awards to honour excellence in women's and newborn health research in our province: the WHRI Early Career Investigator Award and the WHRI Knowledge Translation Award.

Application instructions can be found here: http://whri.org/whri-awards-2nd-annual-womens-health-research-symposium/

The application deadline has been extended to March 31, 2017

Award recipients will be announced at our 2nd Annual Women's Health Research Symposium on Wednesday April 26th, 2017 at the AMS Nest building at UBC. 

 
 

Vancouver proclaims first Sexual and Reproductive Health Awareness Day

Earlier this month, the City of Vancouver proclaimed Sunday, Feb. 12 to be Sexual and Reproductive Health Awareness Day.

The city's designation of this new health awareness day was the result of work done by Maternal Infant Health Canada, a collaborative of doctors and researchers working to improve access to reproductive and infant health care in Canada and around the world.

 
 

MSFHR's Innovation to Commercialization (I2C) Award

MSFHR has recently opened applications for the first Innovation to Commercialization (I2C) awards to support BC health researchers advancing a discovery or invention towards commercialization. 

The I2C Program has been specifically designed to strengthen the health innovation to commercialization pathway in BC, helping researchers bridge the gap between discovery and commercial application.

For more information, eligibility requirements, and details on how to apply please visit the MSFHR website.

In addition, MSFHR's Health Policy Fellowship competition is also open for applications.

 
 

Global Health Research: HPV testing in self collected samples in Uganda

The work of Dr. Gina Ogilvie and her research team is being featured internationally in this month's HPV World newsletter.

The article profiles the Advances in Screening and Prevention in Reproductive Cancers (ASPIRE) study: a community-based HPV self collection project in Uganda that integrates cervical cancer screening with STI & HIV testing and reproductive health education. 

 
 

MSFHR Leadership Update: Dr. Bev Holmes Appointed Interim CEO

The Micheal Smith Foundation for Health Research (MSFHR) recently announced the appointment of Dr. Bev Holmes as the Foundation’s interim president & CEO.

The full announcement can be found here.

 
 

SPOTLIGHT: Engaging Patients in Research

The WHRI is inspired by Canada’s Strategy for Patient-Oriented Research (SPOR). This means that, whenever possible, patients are involved in all aspects of the research process to ensure questions and results are relevant. 

This month, we are highlighting the work of Dr. Paul Yong and his collaborators at BC Women's Centre for Pelvic Pain and Endometriosis as an example of how patients can be engaged in the research process.

Deep dyspareunia (pelvic pain with intercourse or penetration during sexual activity) affects approximately 10% of women. Researchers have tried to study what causes deep dyspareunia and how to treat it, however; research has been hampered by the fact that no one has ever asked women’s input on identifying the best question to measure deep dyspareunia. Dr. Paul Yong is currently leading a study to validate a single-item question about the severity of deep dyspareunia, with two goals.  First, to engage women with deep dyspareunia and to receive their feedback about the question in order to ensure that deep dyspareunia, rather than other types of sexual pain or pelvic pain, is being measured.  Second, to ensure that the question has valid statistical properties such as reproducibility.  This work will allow researchers to better study deep dyspareunia and allow clinicians to better assess deep dyspareunia when seeing patients.

 
 

CIHR Institute of Gender and Health: Funding Opportunities

Planning & Dissemination Grants
Deadline: February 28, 2017

Personalized Health Large-Scale Applied Research Project Competition
Registration deadline: March 16, 2017
Pre-application deadline: May 11, 2017
Full application deadline: October 5, 2017

Global Alliance for Chronic Diseases Mental Health – Canada-China
Deadline: April 11, 2017

Catalyst Grant: Ethics
Deadline: February 28, 2017

Health Systems Impact Fellowships
Deadline: May 9, 2017

New Investigator Grants in Maternal, Reproductive, Child and Youth Health
Registration deadline: April 18, 2017
Application deadline: May 23, 2017